CoChat

The double challenge of resistant hypertension and chronic kidney disease

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Abstract

Resistant hypertension is defined as blood pressure above goal despite adherence to a combination of at least three optimally dosed antihypertensive medications, one of which is a diuretic. Chronic kidney disease is the most frequent of several patient factors or comorbidities associated with resistant hypertension. The prevalence of resistant hypertension is increased in patients with chronic kidney disease, while chronic kidney disease is associated with an impaired prognosis in patients with resistant hypertension. Recommended low-salt diet and triple antihypertensive drug regimens that include a diuretic, should be complemented by the sequential addition of other antihypertensive drugs. New therapeutic innovations for resistant hypertension, such as renal denervation and carotid barostimulation, are under investigation especially in patients with advanced chronic kidney disease. We discuss resistant hypertension in chronic kidney disease stages 3-5 (ie, patients with an estimated glomerular filtration rate below 60 mL/min per 1·73 m(2) and not on dialysis), in terms of worldwide epidemiology, outcomes, causes and pathophysiology, evidence-based treatment, and a call for action.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(15)00418-3

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 102 references

Cited by

See all 194

Metadata

Authors
Rossignol, P., Massy, Z. A., Azizi, M., Bakris, G., Ritz, E., Covic, A., Goldsmith, D., Heine, G. H., Jager, K. J., Kanbay, M., Mallamaci, F., Ortiz, A., Vanholder, R., Wiecek, A., Zoccali, C., London, G. M., Stengel, B., & Fouque, D.
Affiliations
  • Inserm (FR)
  • University of Chicago (US)
  • Heidelberg University (DE)
  • Grigore T. Popa University of Medicine and Pharmacy (RO)
  • Guy's Hospital (GB)
  • Universitätsklinikum des Saarlandes (DE)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Koç University (TR)
  • Istituto di Fisiologia Clinica (IT)
  • Ghent University Hospital (BE)
  • Université de Versailles Saint-Quentin-en-Yvelines (FR)
  • Université de Lyon (FR)
Corresponding author
Rossignol, Patrick
Venue
The Lancet
Publisher
Elsevier BV
Published
2015-10
Volume
386
Issue
10003
Pages
1588-1598
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W1948592297
Cited by
194
References
102
Citations by year
2026: 15 · 2025: 12 · 2024: 10 · 2023: 17 · 2022: 16 · 2021: 14 · 2020: 22 · 2019: 17 · 2018: 18 · 2017: 26 · 2016: 27
FWCI
4.09
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • HAL (submittedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
resistant hypertension, chronic kidney disease, antihypertensive therapy, diuretics, sodium restriction, renal denervation, estimated glomerular filtration rate, hypertension pathophysiology, hypertension epidemiology
MeSH terms
Antihypertensive Agents, Blood Pressure, Diet, Sodium-Restricted, Diuretics, Humans, Hypertension, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The double challenge of resistant hypertension and chronic kidney disease. https://app.cochat.ai/papers/10.1016/s0140-6736(15)00418-3
The paper
Rossignol, P., Massy, Z. A., Azizi, M., Bakris, G., Ritz, E., Covic, A., Goldsmith, D., Heine, G. H., Jager, K. J., Kanbay, M., Mallamaci, F., Ortiz, A., Vanholder, R., Wiecek, A., Zoccali, C., London, G. M., Stengel, B., & Fouque, D. (2015). The double challenge of resistant hypertension and chronic kidney disease. The Lancet. https://doi.org/10.1016/s0140-6736(15)00418-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.